What is the suggested antithrombotic therapy for AF patients requiring OAC undergoing elective PCI/stenting with low bleeding risk (HAS-BLED 0-2)?
We suggest triple therapy for 1 month, followed by dual therapy with OAC plus single antiplatelet (preferably clopidogrel) until 12 months, following which OAC monotherapy can be used (Weak recommendation, low quality evidence).